These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36441509)

  • 1. Synthesis, Structure-Activity Relationships, and
    Hartz RA; Xu L; Sit SY; Chen J; Venables BL; Lin Z; Zhang S; Li Z; Parker D; Simmons TS; Jenkins S; Hanumegowda UM; Dicker I; Krystal M; Meanwell NA; Regueiro-Ren A
    J Med Chem; 2022 Dec; 65(23):15935-15966. PubMed ID: 36441509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation.
    Chen Y; Sit SY; Chen J; Swidorski JJ; Liu Z; Sin N; Venables BL; Parker DD; Nowicka-Sans B; Lin Z; Li Z; Terry BJ; Protack T; Rahematpura S; Hanumegowda U; Jenkins S; Krystal M; Dicker ID; Meanwell NA; Regueiro-Ren A
    Bioorg Med Chem Lett; 2018 May; 28(9):1550-1557. PubMed ID: 29631960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3640254 Is a Novel HIV-1 Maturation Inhibitor with an Optimized Virology Profile.
    Dicker I; Jeffrey JL; Protack T; Lin Z; Cockett M; Chen Y; Sit SY; Gartland M; Meanwell NA; Regueiro-Ren A; Drexler D; Cantone J; McAuliffe B; Krystal M
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0187621. PubMed ID: 34780263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation.
    Regueiro-Ren A; Sit SY; Chen Y; Chen J; Swidorski JJ; Liu Z; Venables BL; Sin N; Hartz RA; Protack T; Lin Z; Zhang S; Li Z; Wu DR; Li P; Kempson J; Hou X; Gupta A; Rampulla R; Mathur A; Park H; Sarjeant A; Benitex Y; Rahematpura S; Parker D; Phillips T; Haskell R; Jenkins S; Santone KS; Cockett M; Hanumegowda U; Dicker I; Meanwell NA; Krystal M
    J Med Chem; 2022 Sep; 65(18):11927-11948. PubMed ID: 36044257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors.
    O'Meara JA; Yoakim C; Bonneau PR; Bös M; Cordingley MG; Déziel R; Doyon L; Duan J; Garneau M; Guse I; Landry S; Malenfant E; Naud J; Ogilvie WW; Thavonekham B; Simoneau B
    J Med Chem; 2005 Aug; 48(17):5580-8. PubMed ID: 16107158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.
    Nowicka-Sans B; Protack T; Lin Z; Li Z; Zhang S; Sun Y; Samanta H; Terry B; Liu Z; Chen Y; Sin N; Sit SY; Swidorski JJ; Chen J; Venables BL; Healy M; Meanwell NA; Cockett M; Hanumegowda U; Regueiro-Ren A; Krystal M; Dicker IB
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3956-69. PubMed ID: 27090171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396.
    Murgatroyd C; Pirrie L; Tran F; Smith TK; Westwood NJ; Adamson CS
    J Virol; 2016 Sep; 90(18):8181-97. PubMed ID: 27384665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands.
    Yang ZH; Bai XG; Zhou L; Wang JX; Liu HT; Wang YC
    Bioorg Med Chem Lett; 2015 May; 25(9):1880-3. PubMed ID: 25838144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolobenzoxazepinone derivatives as non-nucleoside HIV-1 RT inhibitors: further structure-activity relationship studies and identification of more potent broad-spectrum HIV-1 RT inhibitors with antiviral activity.
    Campiani G; Morelli E; Fabbrini M; Nacci V; Greco G; Novellino E; Ramunno A; Maga G; Spadari S; Caliendo G; Bergamini A; Faggioli E; Uccella I; Bolacchi F; Marini S; Coletta M; Nacca A; Caccia S
    J Med Chem; 1999 Oct; 42(21):4462-70. PubMed ID: 10543890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters.
    Hagen SE; Domagala J; Gajda C; Lovdahl M; Tait BD; Wise E; Holler T; Hupe D; Nouhan C; Urumov A; Zeikus G; Zeikus E; Lunney EA; Pavlovsky A; Gracheck SJ; Saunders J; VanderRoest S; Brodfuehrer J
    J Med Chem; 2001 Jul; 44(14):2319-32. PubMed ID: 11428926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1 R,3a S,5a R,5b R,7a R,11a S,11b R,13a R,13b R)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1 H-cyclopenta[ a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176).
    Regueiro-Ren A; Swidorski JJ; Liu Z; Chen Y; Sin N; Sit SY; Chen J; Venables BL; Zhu J; Nowicka-Sans B; Protack T; Lin Z; Terry B; Samanta H; Zhang S; Li Z; Easter J; Beno BR; Arora V; Huang XS; Rahematpura S; Parker DD; Haskell R; Santone KS; Cockett MI; Krystal M; Meanwell NA; Jenkins S; Hanumegowda U; Dicker IB
    J Med Chem; 2018 Aug; 61(16):7289-7313. PubMed ID: 30067361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.
    Campiani G; Aiello F; Fabbrini M; Morelli E; Ramunno A; Armaroli S; Nacci V; Garofalo A; Greco G; Novellino E; Maga G; Spadari S; Bergamini A; Ventura L; Bongiovanni B; Capozzi M; Bolacchi F; Marini S; Coletta M; Guiso G; Caccia S
    J Med Chem; 2001 Feb; 44(3):305-15. PubMed ID: 11462972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
    Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains.
    Jin K; Sang Y; Han S; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2019 Aug; 176():11-20. PubMed ID: 31091477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors: heterocyclic ring systems containing P1' and P2' substituents.
    Kitchin J; Bethell RC; Cammack N; Dolan S; Evans DN; Holman S; Holmes DS; McMeekin P; Mo CL; Nieland N
    J Med Chem; 1994 Oct; 37(22):3707-16. PubMed ID: 7966131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor.
    Joshi SR; Fernando D; Igwe S; McKenzie L; Krishnatry AS; Halliday F; Zhan J; Greene TJ; Xu J; Ferron-Brady G; Lataillade M; Min S
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00671. PubMed ID: 33200887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults.
    Pene Dumitrescu T; Joshi SR; Xu J; Greene TJ; Johnson M; Butcher L; Zimmerman E; Webster L; Pham TT; Lataillade M; Min S
    Br J Clin Pharmacol; 2021 Sep; 87(9):3501-3507. PubMed ID: 33533507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors.
    Liu Z; Swidorski JJ; Nowicka-Sans B; Terry B; Protack T; Lin Z; Samanta H; Zhang S; Li Z; Parker DD; Rahematpura S; Jenkins S; Beno BR; Krystal M; Meanwell NA; Dicker IB; Regueiro-Ren A
    Bioorg Med Chem; 2016 Apr; 24(8):1757-70. PubMed ID: 26968652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.